Status:
COMPLETED
PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy
Lead Sponsor:
Inje University
Conditions:
Heart Valve Diseases
Eligibility:
All Genders
20+ years
Brief Summary
To develop and validate the predictive warfarin dosing algorithm.
Detailed Description
This study aims to develop and validate the predictive warfarin dosing algorithm for personalized warfarin pharmacotherapy in Korean patients.
Eligibility Criteria
Inclusion
- the patients taking warfarin
Exclusion
- noncompliance
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
405 Patients enrolled
Trial Details
Trial ID
NCT01178502
Start Date
March 1 2008
End Date
April 1 2010
Last Update
June 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje University
Busan, South Korea, 614-735